Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMarmara University

About this trial

Despite adequate control of disease activity with standard medical therapies, there remains an ongoing need for complementary and interventional approaches for the management of persistent back pain in patients with ankylosing spondylitis. Although the erector spinae plane block has been described in the literature as a safe and effective analgesic intervention for chronic back pain in various patient populations, to the best of our knowledge, no clinical study has specifically evaluated its use for persistent back pain in patients with ankylosing spondylitis receiving medical treatment. Therefore, the present study aims to evaluate the effects of erector spinae plane block on pain severity and clinical outcomes in patients with ankylosing spondylitis whose disease activity is controlled under treatment but who continue to experience persistent back pain.

Eligibility criteria

Qualifiers

Age between 18 and 65 years

Diagnosis of ankylosing spondylitis according to the Modified New York Criteria

Patients receiving ongoing treatment with controlled disease activity but persistent back pain

Willingness to participate in the study

Disqualifiers

Body mass index (BMI) greater than 35 kg/m²

History of thoracic surgery

Intellectual disability or mental retardation

Presence of major psychiatric comorbidity

Trial design

Treatments tested in this trial

  • Erector spinae plane block(ESBP)

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators